creatine with igf 1 lr3 IGF-I/IGF-1 Protein, Human (83a.a, E51R) IGF-1 LR3 Peptide Therapy in
Description
10.1152/ajpgi.00064.2011 14 ChaboryE.DamonC.LenoirA.KauselmannG.KernH.ZevnikB.et al (2009)
Glucose-dependent insulinotropic polypeptide (GIP)
Four datapoints were excluded for one cage in vehicle group due to food spillage on day 11-14
The standard starting dose is 0.2 mg per night, injected subcutaneously
